Supplementary files: a topical non-steroidal anti-inflammatory cream

Supplementary figure 1. Graphs reporting the modified Seborrheic Dermatitis Area Severity Index (mSDASI) scores as the estimated mean and 95%CI through 12 weeks follow-up; 1A: Estimated mean total mSDASI scores; 1B: Estimated mean erythema scores; 1C: Estimated mean desquamation scores; NSC, a non-steroidal anti-inflammatory cream
* Indicates a significant difference (p < 0.05) between groups

Supplementary figure 2. Percentage of subjects with different Patient Global Assessments at 4, 8, and 12 weeks; NSC, a non-steroidal anti-inflammatory cream

Supplementary figure 3. Percentage changes in skin biophysics reported as the estimated mean and 95%CI through 12 weeks follow-up; 2A: Erythema index; 2B: Hydration; 2C: TEWL; 2D: Sebum levels; NSC, a non-steroidal anti-inflammatory cream; TEWL, Transepidermal water loss
* Indicates a significant difference (p < 0.05) between groups

Supplementary table 1. Ingredients of study products; Supplementary table 2. The results of percentage changes in skin biophysics; Supplementary table 3. Pruritus scales; Supplementary table 4. The results of clinical assessments of mSDASI scores in moderate severity

补充图1：展示12周随访期间改良脂溢性皮炎面积严重指数（modified Seborrheic Dermatitis Area Severity Index, mSDASI）评分的估计均值与95%置信区间（95% confidence interval, 95%CI）的统计图；1A：总mSDASI评分的估计均值；1B：红斑评分的估计均值；1C：脱屑评分的估计均值；NSC为非甾体抗炎乳膏。* 表示组间差异具有统计学意义（p < 0.05）。
补充图2：展示受试者在4周、8周及12周时不同患者整体评估（Patient Global Assessments）占比的统计图；NSC为非甾体抗炎乳膏。
补充图3：展示12周随访期间以估计均值与95%置信区间呈现的皮肤生物物理指标变化百分比的统计图；2A：红斑指数；2B：皮肤含水量；2C：经皮水分丢失（Transepidermal water loss, TEWL）；2D：皮脂水平；NSC为非甾体抗炎乳膏。* 表示组间差异具有统计学意义（p < 0.05）。
补充表1：研究用制剂的成分；补充表2：皮肤生物物理指标变化百分比的相关结果；补充表3：瘙痒量表评分；补充表4：中度脂溢性皮炎患者mSDASI评分的临床评估结果。